Intra-Cellular Therapies, Inc. Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Intra-Cellular Therapies, Inc. for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10 2019 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Option Exercise | A | 0.00 | 68,735 | 0 | 68,735 | |
| Jan 10 2019 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Option Exercise | A | 12.73 | 94,443 | 1,202,259 | 94,443 | |
| Jan 10 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 62,843 | 0 | 62,843 | |
| Jan 10 2019 | ITCI | Intra-Cellular The ... | Neumann Mark | EVP, Chief Commerci ... | Option Exercise | A | 12.73 | 86,348 | 1,099,210 | 86,348 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 125,687 | 0 | 125,687 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 12.73 | 172,697 | 2,198,433 | 172,697 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 6,604 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 125,687 | 0 | 125,687 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 12.43 | 6,604 | 82,088 | 1,138,707 | 1.1 M to 1.1 M (-0.58 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 12.73 | 172,697 | 2,198,433 | 172,697 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 11.82 | 7,539 | 89,111 | 1,145,311 | 1.2 M to 1.1 M (-0.65 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 6,604 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 11.38 | 38,059 | 433,111 | 1,152,850 | 1.2 M to 1.2 M (-3.20 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 12.43 | 6,604 | 82,088 | 1,138,707 | 1.1 M to 1.1 M (-0.58 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 6,604 | 0 | 1,190,909 | 1.2 M to 1.2 M (+0.56 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 11.82 | 7,539 | 89,111 | 1,145,311 | 1.2 M to 1.1 M (-0.65 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 11.38 | 38,059 | 433,111 | 1,152,850 | 1.2 M to 1.2 M (-3.20 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 6,604 | 0 | 1,190,909 | 1.2 M to 1.2 M (+0.56 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 3,108 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 12.42 | 3,108 | 38,601 | 191 | 3.3 K to 191 (-94.21 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 3,108 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 11.80 | 5,398 | 63,696 | 3,299 | 8.7 K to 3.3 K (-62.07 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 12.42 | 3,108 | 38,601 | 191 | 3.3 K to 191 (-94.21 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 11.80 | 5,398 | 63,696 | 3,299 | 8.7 K to 3.3 K (-62.07 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 11.34 | 16,060 | 182,120 | 8,697 | 24.8 K to 8.7 K (-64.87 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 11.34 | 16,060 | 182,120 | 8,697 | 24.8 K to 8.7 K (-64.87 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 3,108 | 0 | 24,757 | 21.6 K to 24.8 K (+14.36 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 3,108 | 0 | 24,757 | 21.6 K to 24.8 K (+14.36 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 3,108 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 3,108 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Gift | G | 0.00 | 1,200 | 0 | 15,832 | 17 K to 15.8 K (-7.05 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Gift | G | 0.00 | 1,200 | 0 | 15,832 | 17 K to 15.8 K (-7.05 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 12.42 | 3,108 | 38,601 | 17,032 | 20.1 K to 17 K (-15.43 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 12.42 | 3,108 | 38,601 | 17,032 | 20.1 K to 17 K (-15.43 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 11.84 | 1,742 | 20,625 | 20,140 | 21.9 K to 20.1 K (-7.96 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 11.84 | 1,742 | 20,625 | 20,140 | 21.9 K to 20.1 K (-7.96 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 11.42 | 19,716 | 225,157 | 21,882 | 41.6 K to 21.9 K (-47.40 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 11.42 | 19,716 | 225,157 | 21,882 | 41.6 K to 21.9 K (-47.40 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 3,108 | 0 | 41,598 | 38.5 K to 41.6 K (+8.07 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 3,108 | 0 | 41,598 | 38.5 K to 41.6 K (+8.07 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 0.00 | 58,915 | 0 | 58,915 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | A | 12.73 | 80,951 | 1,030,506 | 80,951 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 1,554 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 1,554 | 0 | 0 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 12.29 | 592 | 7,276 | 27,068 | 27.7 K to 27.1 K (-2.14 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 12.29 | 592 | 7,276 | 27,068 | 27.7 K to 27.1 K (-2.14 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.81 | 2,184 | 25,793 | 27,660 | 29.8 K to 27.7 K (-7.32 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.81 | 2,184 | 25,793 | 27,660 | 29.8 K to 27.7 K (-7.32 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.37 | 7,380 | 83,911 | 29,844 | 37.2 K to 29.8 K (-19.83 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.37 | 7,380 | 83,911 | 29,844 | 37.2 K to 29.8 K (-19.83 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 1,554 | 0 | 37,224 | 35.7 K to 37.2 K (+4.36 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 1,554 | 0 | 37,224 | 35.7 K to 37.2 K (+4.36 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 54,988 | 0 | 54,988 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 54,988 | 0 | 54,988 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 12.73 | 75,554 | 961,802 | 75,554 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 12.73 | 75,554 | 961,802 | 75,554 | |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 11.80 | 2,702 | 31,884 | 43,989 | 46.7 K to 44 K (-5.79 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 11.80 | 2,702 | 31,884 | 43,989 | 46.7 K to 44 K (-5.79 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 11.33 | 6,862 | 77,746 | 46,691 | 53.6 K to 46.7 K (-12.81 %) |
| Jan 08 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 11.33 | 6,862 | 77,746 | 46,691 | 53.6 K to 46.7 K (-12.81 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 34,340 | 0 | 68,681 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 11,258 | 0 | 11,258 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 34,340 | 0 | 1,184,305 | 1.1 M to 1.2 M (+2.99 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 11,258 | 0 | 1,149,965 | 1.1 M to 1.1 M (+0.99 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 11.09 | 17,478 | 193,831 | 1,138,707 | 1.2 M to 1.1 M (-1.51 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Grant | A | 0.00 | 17,478 | 0 | 1,156,185 | 1.1 M to 1.2 M (+1.53 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 16,160 | 0 | 32,320 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Option Exercise | M | 0.00 | 5,298 | 0 | 5,298 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 16,160 | 0 | 21,649 | 5.5 K to 21.6 K (+294.41 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Buy | M | 0.00 | 5,298 | 0 | 5,489 | 191 to 5.5 K (+2,773.82 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Sell | S | 11.09 | 7,807 | 86,580 | 191 | 8 K to 191 (-97.61 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Halstead Michael | EVP and General Cou ... | Grant | A | 0.00 | 7,807 | 0 | 7,998 | 191 to 8 K (+4,087.43 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 16,160 | 0 | 32,320 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Option Exercise | M | 0.00 | 2,649 | 0 | 2,649 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 16,160 | 0 | 35,670 | 19.5 K to 35.7 K (+82.83 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Buy | M | 0.00 | 2,649 | 0 | 19,510 | 16.9 K to 19.5 K (+15.71 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Sell | S | 11.10 | 4,834 | 53,657 | 16,861 | 21.7 K to 16.9 K (-22.28 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Early Stage Cl ... | Grant | A | 0.00 | 9,322 | 0 | 21,695 | 12.4 K to 21.7 K (+75.34 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 16,160 | 0 | 32,320 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 2,649 | 0 | 2,649 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Buy | M | 0.00 | 16,160 | 0 | 53,553 | 37.4 K to 53.6 K (+43.22 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Buy | M | 0.00 | 2,649 | 0 | 37,393 | 34.7 K to 37.4 K (+7.62 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 11.11 | 4,834 | 53,706 | 34,744 | 39.6 K to 34.7 K (-12.21 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Grant | A | 0.00 | 9,322 | 0 | 39,578 | 30.3 K to 39.6 K (+30.81 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 16,160 | 0 | 32,320 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Option Exercise | M | 0.00 | 5,298 | 0 | 5,298 | |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 16,160 | 0 | 38,490 | 22.3 K to 38.5 K (+72.37 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Buy | M | 0.00 | 5,298 | 0 | 22,330 | 17 K to 22.3 K (+31.11 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Sell | S | 11.09 | 7,807 | 86,580 | 17,032 | 24.8 K to 17 K (-31.43 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | SVP of Finance CFO | Grant | A | 0.00 | 7,807 | 0 | 24,839 | 17 K to 24.8 K (+45.84 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 11.39 | 512 | 5,832 | 4,955 | 4.4 K to 5 K (+11.52 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 11.39 | 1,273 | 14,499 | 40,057 | 38.8 K to 40.1 K (+3.28 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 11.39 | 1,207 | 13,748 | 11,430 | 10.2 K to 11.4 K (+11.81 %) |
| Jan 03 2019 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 11.39 | 1,273 | 14,499 | 748,916 | 747.6 K to 748.9 K (+0.17 %) |